ANZEMET (Avera McKennan Hospital)


Welcome to the PulseAid listing for the ANZEMET drug offered from Avera McKennan Hospital. This Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: dolasetron mesylate
SUBSTANCE NAME: DOLASETRON MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-07-26
END MARKETING DATE: 0000-00-00


ANZEMET HUMAN PRESCRIPTION DRUG Details:

Item DescriptionANZEMET from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 2016-07-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-0679_ce739d48-7487-42d3-a210-c6daec5ef02c
PRODUCT NDC: 69189-0679
APPLICATION NUMBER: NDA020623

Other DOLASETRON MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalANZEMET
sanofi-aventis U.S. LLCAnzemet
Validus Pharmaceuticals LLCANZEMET